Keyphrases
Tumor-specific
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Gastric Cancer Patients
100%
Spatial Metabolomics
100%
Gastric Cancer
66%
Molecular Features
66%
P-EGFR
50%
Tumor
33%
Forkhead Box P3 (FOXP3)
33%
MIB1
33%
Molecular Classification
33%
Tissue Metabolites
33%
Patient Cohort
16%
Tumor Subtype
16%
Treatment Strategy
16%
Specific Treatment
16%
Trastuzumab
16%
Metabolic Difference
16%
Tissue-based
16%
Better Prognosis
16%
Cancer Subtypes
16%
Molecular Characteristics
16%
Classification System
16%
High Mass Resolution
16%
Morphological Characteristics
16%
Metabolic Signature
16%
Imaging Mass Spectrometry
16%
Metabolic Pathway
16%
Multicenter Observational Study
16%
Trastuzumab Therapy
16%
Genomic Features
16%
K-means
16%
Metabolic Pattern
16%
DNA Metabolism
16%
Feature Signatures
16%
Patient Subtypes
16%
HER2-positive Gastric Cancer
16%
CD-8
16%
Validation Cohort
16%
Patient with Tumor
16%
Classification Basis
16%
Tissue Metabolomics
16%
Gastric Cancer Classification
16%
INIS
patients
100%
cancer
100%
tumors
100%
tissues
57%
classification
42%
metabolites
28%
levels
14%
validation
14%
therapy
14%
tools
14%
design
14%
dna
14%
mass spectrometry
14%
metabolism
14%
nucleotides
14%
mass resolution
14%
metabolic pathways
14%
Biochemistry, Genetics and Molecular Biology
Metabolomics
100%
Metabolite
50%
FOXP3
50%
Trastuzumab
50%
Metabolic Pathway
25%
Morphology
25%
Observational Study
25%
DNA Metabolism
25%
CD8
25%
Imaging Mass Spectrometry
25%
Cancer Classification
25%
Genomics
25%